| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Chu Shelley serves as a Director at ODTX. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $200K at current prices.
The biggest single holding is ODTX (~$200K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 11,111 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | ODTX Odyssey Therapeutics, Inc. | Director | Buy | 11,111 | $18.00 | $199,998.00 | New |